Cargando…

Inflammation, Insulin Resistance, and Diabetes—Mendelian Randomization Using CRP Haplotypes Points Upstream

BACKGROUND: Raised C-reactive protein (CRP) is a risk factor for type 2 diabetes. According to the Mendelian randomization method, the association is likely to be causal if genetic variants that affect CRP level are associated with markers of diabetes development and diabetes. Our objective was to e...

Descripción completa

Detalles Bibliográficos
Autores principales: Brunner, Eric J, Kivimäki, Mika, Witte, Daniel R, Lawlor, Debbie A, Smith, George Davey, Cooper, Jackie A, Miller, Michelle, Lowe, Gordon D. O, Rumley, Ann, Casas, Juan P, Shah, Tina, Humphries, Steve E, Hingorani, Aroon D, Marmot, Michael G, Timpson, Nicholas J, Kumari, Meena
Formato: Texto
Lenguaje:English
Publicado: Public Library of Science 2008
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2504484/
https://www.ncbi.nlm.nih.gov/pubmed/18700811
http://dx.doi.org/10.1371/journal.pmed.0050155
_version_ 1782158373388550144
author Brunner, Eric J
Kivimäki, Mika
Witte, Daniel R
Lawlor, Debbie A
Smith, George Davey
Cooper, Jackie A
Miller, Michelle
Lowe, Gordon D. O
Rumley, Ann
Casas, Juan P
Shah, Tina
Humphries, Steve E
Hingorani, Aroon D
Marmot, Michael G
Timpson, Nicholas J
Kumari, Meena
author_facet Brunner, Eric J
Kivimäki, Mika
Witte, Daniel R
Lawlor, Debbie A
Smith, George Davey
Cooper, Jackie A
Miller, Michelle
Lowe, Gordon D. O
Rumley, Ann
Casas, Juan P
Shah, Tina
Humphries, Steve E
Hingorani, Aroon D
Marmot, Michael G
Timpson, Nicholas J
Kumari, Meena
author_sort Brunner, Eric J
collection PubMed
description BACKGROUND: Raised C-reactive protein (CRP) is a risk factor for type 2 diabetes. According to the Mendelian randomization method, the association is likely to be causal if genetic variants that affect CRP level are associated with markers of diabetes development and diabetes. Our objective was to examine the nature of the association between CRP phenotype and diabetes development using CRP haplotypes as instrumental variables. METHODS AND FINDINGS: We genotyped three tagging SNPs (CRP + 2302G > A; CRP + 1444T > C; CRP + 4899T > G) in the CRP gene and measured serum CRP in 5,274 men and women at mean ages 49 and 61 y (Whitehall II Study). Homeostasis model assessment-insulin resistance (HOMA-IR) and hemoglobin A1c (HbA1c) were measured at age 61 y. Diabetes was ascertained by glucose tolerance test and self-report. Common major haplotypes were strongly associated with serum CRP levels, but unrelated to obesity, blood pressure, and socioeconomic position, which may confound the association between CRP and diabetes risk. Serum CRP was associated with these potential confounding factors. After adjustment for age and sex, baseline serum CRP was associated with incident diabetes (hazard ratio = 1.39 [95% confidence interval 1.29–1.51], HOMA-IR, and HbA1c, but the associations were considerably attenuated on adjustment for potential confounding factors. In contrast, CRP haplotypes were not associated with HOMA-IR or HbA1c (p = 0.52–0.92). The associations of CRP with HOMA-IR and HbA1c were all null when examined using instrumental variables analysis, with genetic variants as the instrument for serum CRP. Instrumental variables estimates differed from the directly observed associations (p = 0.007–0.11). Pooled analysis of CRP haplotypes and diabetes in Whitehall II and Northwick Park Heart Study II produced null findings (p = 0.25–0.88). Analyses based on the Wellcome Trust Case Control Consortium (1,923 diabetes cases, 2,932 controls) using three SNPs in tight linkage disequilibrium with our tagging SNPs also demonstrated null associations. CONCLUSIONS: Observed associations between serum CRP and insulin resistance, glycemia, and diabetes are likely to be noncausal. Inflammation may play a causal role via upstream effectors rather than the downstream marker CRP.
format Text
id pubmed-2504484
institution National Center for Biotechnology Information
language English
publishDate 2008
publisher Public Library of Science
record_format MEDLINE/PubMed
spelling pubmed-25044842008-08-12 Inflammation, Insulin Resistance, and Diabetes—Mendelian Randomization Using CRP Haplotypes Points Upstream Brunner, Eric J Kivimäki, Mika Witte, Daniel R Lawlor, Debbie A Smith, George Davey Cooper, Jackie A Miller, Michelle Lowe, Gordon D. O Rumley, Ann Casas, Juan P Shah, Tina Humphries, Steve E Hingorani, Aroon D Marmot, Michael G Timpson, Nicholas J Kumari, Meena PLoS Med Research Article BACKGROUND: Raised C-reactive protein (CRP) is a risk factor for type 2 diabetes. According to the Mendelian randomization method, the association is likely to be causal if genetic variants that affect CRP level are associated with markers of diabetes development and diabetes. Our objective was to examine the nature of the association between CRP phenotype and diabetes development using CRP haplotypes as instrumental variables. METHODS AND FINDINGS: We genotyped three tagging SNPs (CRP + 2302G > A; CRP + 1444T > C; CRP + 4899T > G) in the CRP gene and measured serum CRP in 5,274 men and women at mean ages 49 and 61 y (Whitehall II Study). Homeostasis model assessment-insulin resistance (HOMA-IR) and hemoglobin A1c (HbA1c) were measured at age 61 y. Diabetes was ascertained by glucose tolerance test and self-report. Common major haplotypes were strongly associated with serum CRP levels, but unrelated to obesity, blood pressure, and socioeconomic position, which may confound the association between CRP and diabetes risk. Serum CRP was associated with these potential confounding factors. After adjustment for age and sex, baseline serum CRP was associated with incident diabetes (hazard ratio = 1.39 [95% confidence interval 1.29–1.51], HOMA-IR, and HbA1c, but the associations were considerably attenuated on adjustment for potential confounding factors. In contrast, CRP haplotypes were not associated with HOMA-IR or HbA1c (p = 0.52–0.92). The associations of CRP with HOMA-IR and HbA1c were all null when examined using instrumental variables analysis, with genetic variants as the instrument for serum CRP. Instrumental variables estimates differed from the directly observed associations (p = 0.007–0.11). Pooled analysis of CRP haplotypes and diabetes in Whitehall II and Northwick Park Heart Study II produced null findings (p = 0.25–0.88). Analyses based on the Wellcome Trust Case Control Consortium (1,923 diabetes cases, 2,932 controls) using three SNPs in tight linkage disequilibrium with our tagging SNPs also demonstrated null associations. CONCLUSIONS: Observed associations between serum CRP and insulin resistance, glycemia, and diabetes are likely to be noncausal. Inflammation may play a causal role via upstream effectors rather than the downstream marker CRP. Public Library of Science 2008-08 2008-08-12 /pmc/articles/PMC2504484/ /pubmed/18700811 http://dx.doi.org/10.1371/journal.pmed.0050155 Text en Copyright: © 2008 Brunner et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
spellingShingle Research Article
Brunner, Eric J
Kivimäki, Mika
Witte, Daniel R
Lawlor, Debbie A
Smith, George Davey
Cooper, Jackie A
Miller, Michelle
Lowe, Gordon D. O
Rumley, Ann
Casas, Juan P
Shah, Tina
Humphries, Steve E
Hingorani, Aroon D
Marmot, Michael G
Timpson, Nicholas J
Kumari, Meena
Inflammation, Insulin Resistance, and Diabetes—Mendelian Randomization Using CRP Haplotypes Points Upstream
title Inflammation, Insulin Resistance, and Diabetes—Mendelian Randomization Using CRP Haplotypes Points Upstream
title_full Inflammation, Insulin Resistance, and Diabetes—Mendelian Randomization Using CRP Haplotypes Points Upstream
title_fullStr Inflammation, Insulin Resistance, and Diabetes—Mendelian Randomization Using CRP Haplotypes Points Upstream
title_full_unstemmed Inflammation, Insulin Resistance, and Diabetes—Mendelian Randomization Using CRP Haplotypes Points Upstream
title_short Inflammation, Insulin Resistance, and Diabetes—Mendelian Randomization Using CRP Haplotypes Points Upstream
title_sort inflammation, insulin resistance, and diabetes—mendelian randomization using crp haplotypes points upstream
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2504484/
https://www.ncbi.nlm.nih.gov/pubmed/18700811
http://dx.doi.org/10.1371/journal.pmed.0050155
work_keys_str_mv AT brunnerericj inflammationinsulinresistanceanddiabetesmendelianrandomizationusingcrphaplotypespointsupstream
AT kivimakimika inflammationinsulinresistanceanddiabetesmendelianrandomizationusingcrphaplotypespointsupstream
AT wittedanielr inflammationinsulinresistanceanddiabetesmendelianrandomizationusingcrphaplotypespointsupstream
AT lawlordebbiea inflammationinsulinresistanceanddiabetesmendelianrandomizationusingcrphaplotypespointsupstream
AT smithgeorgedavey inflammationinsulinresistanceanddiabetesmendelianrandomizationusingcrphaplotypespointsupstream
AT cooperjackiea inflammationinsulinresistanceanddiabetesmendelianrandomizationusingcrphaplotypespointsupstream
AT millermichelle inflammationinsulinresistanceanddiabetesmendelianrandomizationusingcrphaplotypespointsupstream
AT lowegordondo inflammationinsulinresistanceanddiabetesmendelianrandomizationusingcrphaplotypespointsupstream
AT rumleyann inflammationinsulinresistanceanddiabetesmendelianrandomizationusingcrphaplotypespointsupstream
AT casasjuanp inflammationinsulinresistanceanddiabetesmendelianrandomizationusingcrphaplotypespointsupstream
AT shahtina inflammationinsulinresistanceanddiabetesmendelianrandomizationusingcrphaplotypespointsupstream
AT humphriesstevee inflammationinsulinresistanceanddiabetesmendelianrandomizationusingcrphaplotypespointsupstream
AT hingoraniaroond inflammationinsulinresistanceanddiabetesmendelianrandomizationusingcrphaplotypespointsupstream
AT marmotmichaelg inflammationinsulinresistanceanddiabetesmendelianrandomizationusingcrphaplotypespointsupstream
AT timpsonnicholasj inflammationinsulinresistanceanddiabetesmendelianrandomizationusingcrphaplotypespointsupstream
AT kumarimeena inflammationinsulinresistanceanddiabetesmendelianrandomizationusingcrphaplotypespointsupstream